Abstract
Diagnostics Focus provides a complete insight into the latest company, product and research developments.
The global in-vitro diagnostic (IVD) testing market is valued at US$28 billion and is set for significant growth. Driven by innovation and a demanding market environment, a number of companies are developing novel, faster and more accurate products.
Diagnostics Focus is a new publication that takes a closer look at the all-important point-of-care and laboratory diagnostics market. The publication aims to cover a wide area of the industry, with specific attention on company activities, performances and alliances, as well as major product and technology developments. From regulatory filings through to product approvals, we hope to provide our subscribers with up to date information on the developments that count.
Anyone who needs to understand the operating landscape for diagnostics need look no further than Diagnostics Focus. This well-written and comprehensive business publication covers all laboratory and point of care diagnostics technologies. Every issue covers the latest:
- Company activities and performance
- Mergers & acquisitions
- Strategic alliances
- Product news
- R&D updates
Table of Contents
Company Activities
- Activities in Brief
- Sphere Medical raises funds through share issue
- Fujirebio acquires CanAg Diagnostics
- Quest makes US$185 million offer to acquire Focus Diagnostics
- AMDL provides update on Chinese acquisition
- Inverness closes subsidiaries and transfers production to key sites in the UK and China
- Asuragen raises funds to aid cancer diagnostic programme
Key alliances
- Utek and AMI enter strategic pact
- Acrongenomics enters joint development pact with Molecular Vision for POC solutions
- Pheromone to proceed with joint venture to develop diabetes treatment
- BioMag selects advisor to manage clinical trials in Thailand
- Trinity Biotech increases share in coagulation market with bioMérieux asset purchase
- Gen-Probe and DiagnoCure provide update on PCA3 collaboration
- FIND and Cepheid work together to develop rapid TB test
- Trinity Biotech participates in supply programme for rapid HIV test
- Alpine Biomed and Medtronic co-develop gastro-enterology diagnostics
- UCDHSC and Source MDx join forces to develop molecular diagnostics for melanoma and psoriasis
- Rosetta and US Genomics work together to develop early detection test for lung cancer
- Xenomics licenses DNA marker for AML
- Atherotech and Source Scientific collaborate to manufacture VAP cholesterol test equipment
Product news
- American Bio Medica gains FDA approval for Rapid TOX
- CE mark for Perceptronix' lung cancer test
- Axis-Shield launches D-dimer test for DVT and PE
- FDA gives green light for Chembio' s rapid HIV tests
- TomTec unveils 4D imaging software for RV diagnostics
- IBL unveils ERC/Mesothelin Expression analysis kit
- OXIS introduces new oncology detection product for HMGA2
- CE marks sought for Zonda tests
Research and development
- Positive results extracted from multi-centre ovarian cancer biomarker validation study
- EFP reports successful results against H9N2 avian influenza strain
- PrecisionMed and Dx Innovations file patent for neuropsychiatric disease diagnostic procedures
- Study confirms sensitivity of Digene' s HPV test
- Positive results released in development of genomic test for colon cancer
- Bayer' s Serum HER-2/neu test predicts clinical outcome to trastuzumab-based therapy in MBC patients
- Colorectal biomarker results verified by Miraculins
- Investigators report benefits of Matritech' s NMP22 BladderChek test at AUA meeting
- diaDexus gains US patent for PLAC test
- BioWarn' s SmartSense system detects avian influenza instantaneously
- MacroArray presents data on diagnostic test for PIN at ASCO
- Paradigm Spine funds trials for diagnostic test to prevent idiopathic scoliosis
- Chinese scientists report on the value of DR-70 for oral cancer patient screening
- Study uncovers high sensitivity rate for EXACT' s stool DNA colorectal cancer screening technology
- Study suggests GlycoMark blood test has a role to playe in diabetes care
- CS-Keys joins fight against breast cancer with new diagnostic tool
- Mayo Clinic report underlines need for more effective diagnosis of patients with suspected pancreatic cancer
- Study finds Glycominds' IBDX biomarkers predict need for surgery in Crohn' s disease patients
- New biomarkers may aid management of prostate cancer
Other News
- Dako and Ventana resolve patent litigation
- Intact Medical' s BLES qualifies for higher reimbursement rate
- Vapaatalo elected Vice Chairman of the Board of Directors of Orion
- Digene' s CEO announces intention to retire
- Upstream Biosciences adds to its scientific advisory board
- OraSure appoints former Chiron executive
